Diligent Pharma
Princeton, US · Founded 2018 · Delaware corporation · 2 known investors
Diligent provides a centralized vendor management platform for clinical trial sponsors to discover, qualify, and oversee vendors, aiming to reduce qualification timelines and mitigate risk. It also maintains VendorBase, a global database where clinical research vendors can get qualified and gain exposure to sponsors seeking partnerships.
Founders & leadership
PL
Patricia LeuchtenNamed on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$3.5M disclosed across 1 round · 2023
▶$3.5MraisedFeb 2023 · 2 investors · Other TechnologyRule 506(b)
▶$3.5MraisedFeb 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Patricia LeuchtenExecutive Officer
- Offering amount
- $9.3M
- Amount sold
- $3.5M
- Minimum investment
- $1
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Diligent Pharma do?
- Diligent provides a centralized vendor management platform for clinical trial sponsors to discover, qualify, and oversee vendors, aiming to reduce qualification timelines and mitigate risk. It also maintains VendorBase, a global database where clinical research vendors can get qualified and gain exposure to sponsors seeking partnerships.
- Who are Diligent Pharma's investors?
- Diligent Pharma's investors include FCA Venture Partners, PJC.
- How much funding has Diligent Pharma raised?
- Diligent Pharma has disclosed $3.5M raised across 1 round.
- Where is Diligent Pharma headquartered?
- Diligent Pharma is headquartered in Princeton, US.